FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2011167201> ?p ?o ?g. }

• W2011167201 endingPage "2393" @default.
• W2011167201 startingPage "2383" @default.
• W2011167201 abstract "Lactoferrin, an iron-binding glycoprotein which belongs to the transferrin family, has been shown to promote bone growth. However, reports regarding effects of lactoferrin on bone regeneration during distraction osteogenesis are limited. Our study was designed to investigate the effect of bovine lactoferrin treatment on bone formation of the distracted callus.We asked whether bovine lactoferrin enhances bone formation of the distraction callus as determined by (1) radiographic and histologic appearances; (2) dual-energy x-ray absorptiometry (DXA) analysis of bone mineral composition and bone mineral density; (3) micro-CT measures of trabecular architecture; and (4) biomechanical strength of the healing bone. Additionally, serology, reverse transcription (RT)-PCR, and immunohistochemistry were used to explore the possible mechanisms of bovine lactoferrin use on bone formation during distraction osteogenesis.Unilateral tibial osteodistraction was performed on 80 New Zealand White rabbits with a distraction rate of 1 mm per day for 10 days. Animals then were divided randomly into two groups: (1) vehicle and (2) bovine lactoferrin. At 4 and 8 weeks after completion of distraction, the animals were sacrificed. Lengthened tibias and serum samples were obtained and subjected to radiologic, DXA, micro-CT, histologic, and biomechanical examinations, and serum, RT-PCR and immunohistochemical analyses.Radiologic, DXA, micro-CT, histologic, and biomechanical examinations indicated that bovine lactoferrin treatment not only accelerated bone formation at early stages of distraction osteogenesis but also promoted bone consolidation at late stages. The ultimate force of the distracted calluses was increased by 37% (118.8 ± 6.65 N in the lactoferrin group and 86.5 ± 5.47 N in the vehicle group; p < 0.001) and 84% (384.8 ± 18.4 N in the lactoferrin group and 209.0 ± 15.2 N in the vehicle group; p < 0.001) at 4 and 8 weeks, respectively. Moreover, serum analysis showed that bovine lactoferrin treatment significantly increased serum levels of bone alkaline phosphatase and decreased serum levels of tartrate resistant acid phosphatase 5b. In addition, RT-PCR and immunohistochemical analyses suggested that bovine lactoferrin treatment induced a lower receptor activator of nuclear factor-kappaB (RANK) ligand/osteoprotegerin (RANKL/OPG) ratio in the distracted callus.The results of our study suggest that bovine lactoferrin treatment could promote bone regeneration during distraction osteogenesis in the rabbit. The results indicate that the OPG/RANKL/RANK system might be a major mechanism for increased bone formation and decreased bone resorption in distraction osteogenesis with bovine lactoferrin treatment.Oral administration of bovine lactoferrin may provide a feasible approach for promoting osteogenesis during distraction osteogenesis." @default.
• W2011167201 created "2016-06-24" @default.
• W2011167201 creator A5034656429 @default.
• W2011167201 creator A5079351209 @default.
• W2011167201 creator A5088027886 @default.
• W2011167201 date "2015-07-01" @default.
• W2011167201 modified "2023-10-14" @default.
• W2011167201 title "Bone Regeneration Is Promoted by Orally Administered Bovine Lactoferrin in a Rabbit Tibial Distraction Osteogenesis Model" @default.
• W2011167201 cites W141827646 @default.
• W2011167201 cites W162792278 @default.
• W2011167201 cites W1949927726 @default.
• W2011167201 cites W1970032137 @default.
• W2011167201 cites W2000456607 @default.
• W2011167201 cites W2005023595 @default.
• W2011167201 cites W2010715825 @default.
• W2011167201 cites W2015357546 @default.
• W2011167201 cites W2016386543 @default.
• W2011167201 cites W2016419998 @default.
• W2011167201 cites W2019257051 @default.
• W2011167201 cites W2023166799 @default.
• W2011167201 cites W2027605449 @default.
• W2011167201 cites W2039667585 @default.
• W2011167201 cites W2040105788 @default.
• W2011167201 cites W2046393728 @default.
• W2011167201 cites W2059840692 @default.
• W2011167201 cites W2062980873 @default.
• W2011167201 cites W2066260122 @default.
• W2011167201 cites W2066516540 @default.
• W2011167201 cites W2074280330 @default.
• W2011167201 cites W2074565049 @default.
• W2011167201 cites W2089940606 @default.
• W2011167201 cites W2092895549 @default.
• W2011167201 cites W2097799058 @default.
• W2011167201 cites W2116232110 @default.
• W2011167201 cites W2116333857 @default.
• W2011167201 cites W2123153566 @default.
• W2011167201 cites W2130452566 @default.
• W2011167201 cites W2137305295 @default.
• W2011167201 cites W2142887988 @default.
• W2011167201 cites W2155496317 @default.
• W2011167201 cites W2166465277 @default.
• W2011167201 cites W2211012831 @default.
• W2011167201 cites W2472167186 @default.
• W2011167201 cites W4292425573 @default.
• W2011167201 doi "https://doi.org/10.1007/s11999-015-4270-5" @default.
• W2011167201 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4457759" @default.
• W2011167201 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25822454" @default.
• W2011167201 hasPublicationYear "2015" @default.
• W2011167201 type Work @default.
• W2011167201 sameAs 2011167201 @default.
• W2011167201 citedByCount "46" @default.
• W2011167201 countsByYear W20111672012016 @default.
• W2011167201 countsByYear W20111672012017 @default.
• W2011167201 countsByYear W20111672012018 @default.
• W2011167201 countsByYear W20111672012019 @default.
• W2011167201 countsByYear W20111672012020 @default.
• W2011167201 countsByYear W20111672012021 @default.
• W2011167201 countsByYear W20111672012022 @default.
• W2011167201 countsByYear W20111672012023 @default.
• W2011167201 crossrefType "journal-article" @default.
• W2011167201 hasAuthorship W2011167201A5034656429 @default.
• W2011167201 hasAuthorship W2011167201A5079351209 @default.
• W2011167201 hasAuthorship W2011167201A5088027886 @default.
• W2011167201 hasBestOaLocation W20111672011 @default.
• W2011167201 hasConcept C105702510 @default.
• W2011167201 hasConcept C142724271 @default.
• W2011167201 hasConcept C169760540 @default.
• W2011167201 hasConcept C199343813 @default.
• W2011167201 hasConcept C2776378700 @default.
• W2011167201 hasConcept C2776541429 @default.
• W2011167201 hasConcept C2776819169 @default.
• W2011167201 hasConcept C2776886416 @default.
• W2011167201 hasConcept C2777236700 @default.
• W2011167201 hasConcept C2779170986 @default.
• W2011167201 hasConcept C55493867 @default.
• W2011167201 hasConcept C71924100 @default.
• W2011167201 hasConcept C81880429 @default.
• W2011167201 hasConcept C8337478 @default.
• W2011167201 hasConcept C86803240 @default.
• W2011167201 hasConceptScore W2011167201C105702510 @default.
• W2011167201 hasConceptScore W2011167201C142724271 @default.
• W2011167201 hasConceptScore W2011167201C169760540 @default.
• W2011167201 hasConceptScore W2011167201C199343813 @default.
• W2011167201 hasConceptScore W2011167201C2776378700 @default.
• W2011167201 hasConceptScore W2011167201C2776541429 @default.
• W2011167201 hasConceptScore W2011167201C2776819169 @default.
• W2011167201 hasConceptScore W2011167201C2776886416 @default.
• W2011167201 hasConceptScore W2011167201C2777236700 @default.
• W2011167201 hasConceptScore W2011167201C2779170986 @default.
• W2011167201 hasConceptScore W2011167201C55493867 @default.
• W2011167201 hasConceptScore W2011167201C71924100 @default.
• W2011167201 hasConceptScore W2011167201C81880429 @default.
• W2011167201 hasConceptScore W2011167201C8337478 @default.
• W2011167201 hasConceptScore W2011167201C86803240 @default.
• W2011167201 hasIssue "7" @default.
• W2011167201 hasLocation W20111672011 @default.
• W2011167201 hasLocation W20111672012 @default.
• W2011167201 hasLocation W20111672013 @default.

• next